Mode
Text Size
Log in / Sign up

Active stone-directed intervention reduces odds of composite recurrence and surgery for asymptomatic kidney stonesActive Intervention Reduces Surgery for Patients with Kidney Stones

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that active stone-directed intervention reduces odds of recurrence and surgery for asymptomatic kidney stones.

This meta-analysis evaluated the impact of active stone-directed intervention versus observation in 592 patients with asymptomatic kidney stones. The primary finding was a significant reduction in the odds of composite stone-related recurrence (OR 0.35; 95% CI 0.18-0.69) and subsequent surgery (OR 0.45; 95% CI 0.25-0.80) for those receiving active intervention.

Secondary outcomes showed mixed results. While stone growth was reduced in two studies (OR 0.24; 95% CI 0.09-0.59), the effect on unscheduled stone-related visits was not statistically significant (OR 0.31; 95% CI 0.07-1.28). Fragment passage did not reach statistical significance due to high heterogeneity (OR 7.32; 95% CI 0.44-122.34).

The authors noted several limitations, including a limited number of trials, heterogeneous intervention types, and variable outcome definitions. These factors led to imprecise estimates for certain outcomes like fragment passage. Clinical application should be cautious as the evidence for some specific outcomes is less certain due to high heterogeneity.

Active intervention may reduce subsequent surgery in selected patients with asymptomatic kidney stones without a clear increase in adverse events. However, the variety of interventions and limited trial volume mean results should be applied selectively based on individual patient profiles.

Researchers analyzed data from 592 patients with asymptomatic kidney stones to see if active interventions could improve outcomes. The study looked at several factors, including whether patients needed more surgery, experienced stone growth, or had to make unscheduled visits for their condition.

The results showed that patients who received an active intervention had lower odds of undergoing subsequent surgeries and a lower risk of stone growth compared to those who were only observed. While the data suggested fewer unscheduled clinic visits for those with active treatment, this specific finding was not statistically significant. Safety reports indicated that there were no significant differences in adverse events between the two groups.

It is important to note that this research involved a limited number of trials and varied methods of intervention. Because of these factors, some results like fragment passage were less certain. These findings suggest that active treatment might be a helpful option for specific patients to reduce future surgeries, but you should speak with your doctor to determine the best plan for your specific situation.

What this means for you:
Active intervention may lower surgery risks and stone growth in some patients with asymptomatic kidney stones.

Common questions

Does active intervention make it safer?

The study found that there were similar rates of adverse events between patients who received an active intervention and those who were only observed. This suggests that the treatment did not lead to a clear increase in safety concerns for these patients.

Can this help prevent more surgeries?

The data showed lower odds of subsequent surgery for patients receiving an active intervention compared to those who were just observed. This suggests it may be a helpful option for reducing future procedures in certain cases.

Does the treatment stop stones from growing?

In two of the studies reviewed, active intervention was linked to reduced stone growth. However, because there were only a limited number of trials and different types of interventions used, results can vary between patients.

Study Details

Study typeMeta analysis
Sample sizen = 592
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: The detection rate of asymptomatic stones has increased with advances in imaging technology. Although many such stones remain stable, some patients later experience pain, obstruction, infection, stone growth, or need for intervention. Current guideline-based management generally favors surveillance for many asymptomatic stones while emphasizing individualized shared decision-making. We therefore conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to compare active stone-directed intervention versus observation for asymptomatic kidney stones. METHODS: We systematically searched PubMed, Embase, and the Cochrane Library from database inception to April 22, 2026, using a broad concept-based strategy combining terms for asymptomatic kidney stones and stone-directed interventions. Procedure-specific terms such as ureteroscopy, shock wave lithotripsy, and ultrasonic propulsion were included to improve sensitivity. Only RCTs comparing active intervention with observation were eligible. The primary synthesis focused on a composite stone-related recurrence outcome, with subsequent surgery, unscheduled stone-related visits, stone growth, fragment passage, and adverse events analyzed as secondary outcomes. RESULTS: Six RCTs involving 592 participants were included. Compared with observation, active intervention showed lower pooled odds of composite recurrence (OR 0.35, 95% CI 0.18-0.69; I²=56.3%) and subsequent surgery (OR 0.45, 95% CI 0.25-0.80; I²=0%). The pooled estimate for unscheduled visits favored intervention numerically but was not statistically significant (OR 0.31, 95% CI 0.07-1.28; I²=67.3%). Stone growth was reduced in two studies (OR 0.24, 95% CI 0.09-0.59; I²=0%), whereas fragment passage was highly heterogeneous and not statistically significant (OR 7.32, 95% CI 0.44-122.34; I²=90%). Adverse events were similar between groups (OR 1.16, 95% CI 0.66-2.03; I²=0.2%). CONCLUSION: Active intervention may reduce subsequent stone-related surgery in selected patients with asymptomatic kidney stones, without a clear increase in adverse events. However, evidence for other outcomes remains uncertain because of the limited number of trials, heterogeneous interventions, variable outcome definitions, and imprecise estimates. When considering treatment strategies, individualized joint decision-making should be supported instead of applying routine intervention measures to all asymptomatic stones.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.